Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Cottin

Showing results (91-100 of 279) with videos related to

Pageof 28
Sort By:
Toxicology and Applied Pharmacology|February 26, 2015
Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in miceCharles Guenancia, Na Li, Olivier Hachet, et al.
Journal of the American Heart Association|July 9, 2024
Type 2 Myocardial Infarction in a Sub-Saharan Africa Population: Challenging the Current Concepts-Data From REACTIVHermann Yao, Camille Touré, Arnaud Ekou, et al.
Annales Pharmaceutiques Francaises|April 30, 2024
Glycemic and lipid control in patients with diabetes at time of myocardial infarctionChristelle Lacqua, Héloïse Adam, Marianne Zeller, et al.
Cardiovascular Diabetology|January 29, 2016
Early cardiovascular events in women with a history of gestational diabetes mellitusKarine Goueslard, Jonathan Cottenet, Anne-Sophie Mariet, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2016
Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicityCharles Guenancia, Olivier Hachet, Mona Aboutabl, et al.
Journal of Clinical Medicine|January 8, 2020
Growth Differentiation Factor-8 (GDF8)/Myostatin is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial InfarctionAlexandre Meloux, Luc Rochette, Maud Maza, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2022
Impact of first COVID-19 lockdown on paediatric and adult haemophilia patients treated in a French Haemophilia Comprehensive Care CentreFabienne Volot, Agnes Soudry-Faure, Anamaria Callegarin, et al.
Archives of Cardiovascular Diseases|August 12, 2009
Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohortLuc Lorgis, Marianne Zeller, Patrick Jourdain, et al.
Journal of Personalized Medicine|June 24, 2022
Retinal Microvascular Changes in Familial Hypercholesterolemia: Analysis with Swept-Source Optical Coherence Tomography AngiographyPétra Eid, Louis Arnould, Pierre-Henry Gabrielle, et al.
International Journal of Cardiology|August 27, 2014
Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factorCharles Guenancia, Karim Stamboul, Fabien Garnier, et al.
Pageof 28

Showing results (91-100 of 279) with videos related to

Sort By:
Pageof 28
Toxicology and Applied Pharmacology|February 26, 2015
Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in miceCharles Guenancia, Na Li, Olivier Hachet, et al.
Journal of the American Heart Association|July 9, 2024
Type 2 Myocardial Infarction in a Sub-Saharan Africa Population: Challenging the Current Concepts-Data From REACTIVHermann Yao, Camille Touré, Arnaud Ekou, et al.
Annales Pharmaceutiques Francaises|April 30, 2024
Glycemic and lipid control in patients with diabetes at time of myocardial infarctionChristelle Lacqua, Héloïse Adam, Marianne Zeller, et al.
Cardiovascular Diabetology|January 29, 2016
Early cardiovascular events in women with a history of gestational diabetes mellitusKarine Goueslard, Jonathan Cottenet, Anne-Sophie Mariet, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2016
Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicityCharles Guenancia, Olivier Hachet, Mona Aboutabl, et al.
Journal of Clinical Medicine|January 8, 2020
Growth Differentiation Factor-8 (GDF8)/Myostatin is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial InfarctionAlexandre Meloux, Luc Rochette, Maud Maza, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2022
Impact of first COVID-19 lockdown on paediatric and adult haemophilia patients treated in a French Haemophilia Comprehensive Care CentreFabienne Volot, Agnes Soudry-Faure, Anamaria Callegarin, et al.
Archives of Cardiovascular Diseases|August 12, 2009
Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohortLuc Lorgis, Marianne Zeller, Patrick Jourdain, et al.
Journal of Personalized Medicine|June 24, 2022
Retinal Microvascular Changes in Familial Hypercholesterolemia: Analysis with Swept-Source Optical Coherence Tomography AngiographyPétra Eid, Louis Arnould, Pierre-Henry Gabrielle, et al.
International Journal of Cardiology|August 27, 2014
Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factorCharles Guenancia, Karim Stamboul, Fabien Garnier, et al.
Pageof 28